However, because neurotrophic factors have been reported to play a potential role in cancer aggressiveness [3], we performed a systematic preclinical and clinical evaluation of the effect of GDNF in HNSCC through the use of several different cell lines and patient cohorts. The gene discussed is GDNF; the disease is head and neck squamous cell carcinoma.